Search bioRxiv⌕ Search

bioRxiv · 10.1101/106229

Promoter and transcription factor dynamics tune protein mean and noise strength in a quorum sensing-based feedback synthetic circuit

Abstract

Gene expression is a fundamental cellular process. Its stochastic fluctuations due to intrinsic and extrinsic sources, known generically as gene expression noise, trigger both beneficial and harmful consequences for the cell behavior.\n\nControlling gene expression noise is of interest in many applications in biotechnology, biomedicine and others. Yet, control of the mean expression level is an equally desirable goal. Here, we analyze a gene synthetic network designed to reduce gene expression noise while achieving a desired mean expression level. The circuit combines a negative feedback loop over the gene of interest, and a cell-to-cell communication mechanism based on quorum sensing. We analyze the ability of the circuit to reduce noise as a function of parameters that can be tuned in the wet-lab, and the role quorum sensing plays. Intrinsic noise is generated by the inherent stochasticity of biochemical reactions. On the other hand, extrinsic noise is due to variability in the cell environment and the amounts of cellular components that affect gene expression. We develop a realistic model of the gene synthetic circuit over the population of cells using mass action kinetics and the stochastic Chemical Langevin Equation to include intrinsic noise, with parameters drawn from a distribution to account for extrinsic noise. Stochastic simulations allow us to quantify the mean expression level and noise strength of all species under different scenarios, showing good agreement with system-wide available experimental data of protein abundance and noise in E. coli. Our in silico experiments reveal significant noise attenuation in gene expression through the interplay between quorum sensing and the negative feedback, allowing control of the mean expression and variance of the protein of interest. These in silico conclusions are validated by preliminary experimental results. This gene network could have important implications as a robust protein production system in industrial biotechnology.\n\nAuthor SummaryControlling gene expression level is of interest in many applications in biotechnology, biomedicine and others. Yet, the stochastic nature of biochemical reactions plays an important role in biological systems, and cannot be disregarded. Gene expression noise resulting from this stochasticity has been studied over the past years both in vivo, and in silico using mathematical models. Nowadays, synthetic biology approaches allow to design novel biological circuits, drawing on principles elucidated from biology and engineering, for the purpose of decoupled control of mean gene expression and its variance. We propose a gene synthetic circuit with these characteristics, using negative feedback and quorum sensing based cell-to-cell communication to induce population consensus. Our in silico analysis using stochastic simulations with a realistic model reveal significant noise attenuation in gene expression through the interplay between quorum sensing and the negative feedback, allowing control of the mean expression and variance of the protein of interest. Preliminary in vivo results fully agree with the computational ones.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Boada, Y., Vignoni, A., Pico, J.. 2017-02-06. Promoter and transcription factor dynamics tune protein mean and noise strength in a quorum sensing-based feedback synthetic circuit. https://doi.org/10.1101/106229

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Machine learning guided design of strong transcriptional activation domains

Artificial intelligence has accelerated the design of structured proteins, but it remains difficult to design functional intrinsically disordered proteins because of weak structural constraints and poorly defined sequence-to-function relationships1. Activation domains (ADs), transcription factor regions that recruit coactivators, are an excellent test case for the de novo design of intrinsically disordered sequences. ADs are one of the oldest groups of functional intrinsically disordered sequences2 and designed ADs have applications in synthetic biology, biotechnology, and agriculture. We computationally generated 500,000 candidate sequences that resembled known ADs and predicted AD function with extant machine learning models, including three neural networks. From high-scoring sequences, we selected 18,750 for experimental validation in yeast. Surprisingly, >90% of the 16,770 well-measured sequences function as ADs. Sequences predicted to be active by multiple models were stronger, motivating development of a fast and accurate consensus AD predictor, MADRIGAL. A number of our designed ADs retain functionality across fungi, plants, and human cells. This work illustrates a generalizable paradigm for incorporating sequence-to-function models into the design loop to efficiently generate functional intrinsically disordered sequences.

synthetic biology↗

E. coli-produced nanobody fusions as a pan-serotype platform for AAV purification, quantification, and detection

Research, production and application of the recombinant adeno-associated virus (rAAV) require versatile tools for rapid and cost-effective advances. We developed fusion constructs with the pan-serotype, AAV-binding VHH-antibody-fragment named nanobody AAVX and devised procedures for AAV purification, quantification, and detection. Starting from an amino acid sequence, we cytosolically expressed in E. coli nanobody AAVX carrying various tags and fusion partners. Very efficient soluble production followed by a one-step immobilized metal-ion affinity chromatography (IMAC) yielded mostly >90% pure protein. Crosslinking AAVX with an agarose matrix enabled efficient purification of intact AAV2 and AAV5 capsids from cell lysates, as assessed by qPCR and ELISA. AAVX also supported effective AAV quantification by ELISA, as capture reagent and, when fused to luciferase, as detection reagent. Using tagged AAVX and streptavidin biosensors, we developed a rapid and label-free quantification assay of AAV capsids by biolayer interferometry (BLI). Finally, immunostaining with an AAVX-eGFP fusion visualized AAV capsids in fixed HEK-293 cells by fluorescence microscopy. Collectively, these results establish nanobody AAVX fusion proteins as versatile and readily customizable tools for AAV research and bioprocessing.

synthetic biology↗

Duality Vaccination through Nanodesign of Click-Ligated B-Cell Inhibitory Receptor Bridging

Synthesis of precise and robust molecular architectures is critical to harness the power of the immune system. The dimensions, rigidity and multivalency of nanoparticles contribute to eliciting high levels of antibodies from vaccination. However, antibodies vary hugely in quality: some antibodies are highly effective at neutralizing pathogens, while others provide little or no benefit. Here we establish switchable and modular platforms for protein and nanoparticle assembly that program the target of antibody responses. We introduce Duality vaccination: the simultaneous delivery of activating and inhibitory stimuli for focusing immune responses. To construct activatory immunogens, we employ click biology with spontaneous amidation to functionalize plug-and-display self-assembling porous dodecahedral nanocages. We construct inhibitory immunogens using SpyMask protease-gated bispecific assembly, ligating the antigen to binders that bridge the B cell receptor to immune checkpoint receptors. This dual immunogen architecture tailors the elicited antibodies to down-modulate undesired B cell responses. We establish the effect of temporal and spatial separation of activatory and inhibitory immunogen delivery. We further explore sensitivity to valency, linker flexibility and adjuvant delivery, employing model targets and coronavirus antigens. Dual programmable functionalization identifies key nanodesign features to control in vivo outputs, providing logic-gating towards urgent challenges in the creation of protective vaccines.

synthetic biology↗